Recent TSHA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 12:32:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:05:53 PM
- Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/12/2024 12:01:00 PM
- Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12 • GlobeNewswire Inc. • 08/05/2024 12:00:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/02/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/05/2024 09:51:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/05/2024 09:50:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/05/2024 09:49:24 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/05/2024 12:00:00 PM
- Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 06/26/2024 01:14:46 PM
- Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 06/25/2024 10:34:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 11:45:05 AM
- Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome • GlobeNewswire Inc. • 06/18/2024 11:30:00 AM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:18:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:18:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:12:35 PM
- Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/14/2024 08:01:00 PM
- Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14 • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:05:00 PM
- Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/05/2024 12:00:00 PM
- Another Biotech Steals The Show Following Major Clinical Data Release • AllPennyStocks.com • 03/20/2024 05:30:00 PM
- Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates • GlobeNewswire Inc. • 03/19/2024 08:01:00 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM